Cargando…
Acquired hemophilia in a 7‐year‐old girl successfully treated with recombinant FVIIA and steroids: A case report
Acquired hemophilia should be evaluated in pediatric patients with bleeding and isolated prolonged aPTT. Immunosuppressive treatment should be initiated even in minor bleedings. Bypassing agents like rFVIIa can be used in children with success.
Autores principales: | Giuffrida, Gaetano, Markovic, Uros, Parisi, Marina, Nicolosi, Daniela, Calafiore, Valeria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7869384/ https://www.ncbi.nlm.nih.gov/pubmed/33598217 http://dx.doi.org/10.1002/ccr3.3588 |
Ejemplares similares
-
A rare case of acquired factor V inhibitor, during treatment with dabigatran for chronic atrial fibrillation, successfully treated with bypassing agents
por: Giuffrida, Gaetano, et al.
Publicado: (2020) -
Acquired hemophilia A following COVID-19 vaccination – The importance of prompt diagnosis: A case report
por: Duminuco, Andrea, et al.
Publicado: (2022) -
Status of Recombinant Factor VIII Concentrate Treatment for Hemophilia A in Italy: Characteristics and Clinical Benefits
por: Schiavoni, Mario, et al.
Publicado: (2019) -
Life-threatening bleeding in a patient with pemphigoid-induced acquired hemophilia A and successfully treated with rituximab and rFVIIa: A case report
por: Ma, Hongbing, et al.
Publicado: (2021) -
Glucosylsphingosine (Lyso-Gb1) as a reliable biomarker in Gaucher disease: a narrative review
por: Giuffrida, Gaetano, et al.
Publicado: (2023)